Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zealand Pharma

Request full access

Discovery, design and development of innovative peptide-based medicines

Søborg, DenmarkFounded 1998Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2017

Zealand Pharma in the Søborg ecosystem

Live from Dealroom

The Zealand Pharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later4 investors entered at this stage

  • Van Herk Investments
  • Sanofi-Genzyme BioVentures
  • Kurma Partners
  • HBM Healthcare Investments

Ownership

Share of equity by holder

Share of equity by holder, from Dealroom's shareholder data. Stakes as last recorded by Dealroom (2026).

7.5% Van Herk Investments B.V.

“Other / undisclosed” is the 72.5% not attributed to a named shareholder. See the full cap table on Dealroom →

Employees mapped 618 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 16 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$240M

117 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Zealand Pharma was the backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Zealand Pharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Zealand Pharma deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Zealand Pharma's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        See Zealand Pharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.